Randomized parallel control trial checking the efficacy and impact of two concentrations of retinol in the original formula on the aging skin condition: Pilot study
- 21 June 2019
- journal article
- research article
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (2) , 437-443
Abstract
Background: The aging process is defined as natural, biological, progressive, and physiologically irreversible phenomena occurring in the body.Objective: We attempted to evaluate the efficacy and tolerability of treating signs of the aging skin using retinol 0.15% and 0.3%. Retinol was added to the original, developed liquid crystal formula.Methods: Patients at two sites (n = 20, n = 20) presenting signs of aging applied a novel formulation of retinol at 0.15% (on the left) and 0.3% (on the right) concentrations daily to their faces for 2 months. An expert blinded evaluation of images was carried out after 8 weeks. Tolerability was assessed throughout the whole study. Positive results of the observational pilot study guaranteed a follow‐up trial with the use of the higher concentration and another parallel study.Results: In the observational pilot study, most of the participants showed an improvement in the overall skin condition. These improvements were assessed after 4 and 8 weeks. Those observed after 56 days were more remarkable than those identified 28 days, however, without any statistical significance. Application of retinol formula 0.3% and serum 0.15% gives similar results after 8 weeks of daily care. Both products improve the overall skin condition considerably, even the skin color, hydration, and radiance. In a VAS assessment, the number of wrinkles decreased and skin discoloration was reduced. Side effects such as burning, dryness, pruritus, and erythema during the 8‐week study period were minimal.Conclusions: The topical formulation of liquid crystal serum with retinol 0.15% and 0.3% improves the overall skin condition after 8 weeks. Burning, pruritus, dryness, and erythema caused by the application of retinol 0.15% and 0.3% concentrations were minimal. Nevertheless, there were no significance changes found between the left and right side of the face. These encouraging results justify a longer‐term study to determine whether topically applied retinol 0.3% can provide more benefits as compared to those observed after topical application of retinol 0.15%.Keywords
Funding Information
- Uniwersytet Medyczny w Łodzi (502-03/3-066-02/502-34-094)
This publication has 16 references indexed in Scilit:
- Molecular basis of retinol anti‐ageing properties in naturally aged human skin in vivoInternational Journal of Cosmetic Science, 2016
- Topical Retinoids in Skin Ageing: A Focused Update with Reference to Sun-Induced Epidermal Vitamin A DeficiencyDermatology, 2014
- Proposed mechanisms of action for retinoid derivatives in the treatment of skin agingJournal of Cosmetic Dermatology, 2005
- PhotoagingClinics in Geriatric Medicine, 2001
- The role of retinoids in the prevention and repair of aged and photoaged skinClinical and Experimental Dermatology, 2001
- Aesthetic and anatomic analysis of the aging skinSeminars in Cutaneous Medicine and Surgery, 1996
- Tretinoin emollient cream: A new therapy for photodamaged skinJournal of the American Academy of Dermatology, 1992
- Topical retinoic acid for treatment of solar damageBritish Journal of Dermatology, 1990
- Topical Tretinoin Improves Photoaged SkinJAMA, 1988
- Topical tretinoin for photoaged skinJournal of the American Academy of Dermatology, 1986